GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visiomed Group (XPAR:ALVMG) » Definitions » Gross-Profit-to-Asset %

Visiomed Group (XPAR:ALVMG) Gross-Profit-to-Asset % : 17.73% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Visiomed Group Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Visiomed Group's annualized Gross Profit for the quarter that ended in Dec. 2023 was €6.38 Mil. Visiomed Group's average Total Assets over the quarter that ended in Dec. 2023 was €35.97 Mil. Therefore, Visiomed Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 17.73%.


Visiomed Group Gross-Profit-to-Asset % Historical Data

The historical data trend for Visiomed Group's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visiomed Group Gross-Profit-to-Asset % Chart

Visiomed Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -47.48 -36.43 -2.86 7.99 17.33

Visiomed Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.59 7.90 9.37 17.41 17.73

Competitive Comparison of Visiomed Group's Gross-Profit-to-Asset %

For the Medical Instruments & Supplies subindustry, Visiomed Group's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Visiomed Group's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visiomed Group's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Visiomed Group's Gross-Profit-to-Asset % falls into.



Visiomed Group Gross-Profit-to-Asset % Calculation

Visiomed Group's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=6.298/( (36.085+36.597)/ 2 )
=6.298/36.341
=17.33 %

Visiomed Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=6.378/( (35.347+36.597)/ 2 )
=6.378/35.972
=17.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Visiomed Group Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Visiomed Group's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Visiomed Group (XPAR:ALVMG) Business Description

Traded in Other Exchanges
Address
8, Avenue Kléber, Paris, FRA, 75116
Visiomed Group is engaged in the development, designing, and marketing of medical products. The product portfolio includes various thermometers, natural mud, cold spray, connected activity bracelets, connected scales, inhalers, humidifiers, baby flies, natural wax, comfort foam, antibacterial solutions, baby nutrition, baby accessories, among others.

Visiomed Group (XPAR:ALVMG) Headlines

No Headlines